Ambetter GLP-1 Coverage for Weight Loss (2026)
If you have an Ambetter plan, or you are thinking about buying one, you want to know whether it will pay for a GLP-1 medication for weight loss. Ambetter is the brand Centene uses for individual and family plans sold through the health insurance marketplace, and each state’s Ambetter plan has its own name and its own drug list. That is why answers online often conflict.
Here is what Ambetter’s and Centene’s own documents say as of 2026-10-16, which states we checked, and how to confirm the answer for your plan.
Transformation Health is an independent guide, not a provider, and is not affiliated with Ambetter or Centene: we do not prescribe, sell medication, or work with insurance. This content is for general education and is not medical advice. Talk with a licensed provider about your situation.
The short answer
Based on the documents we checked, Ambetter marketplace plans generally do not cover GLP-1 medications prescribed for weight loss. As of 2026-10-16:
- Centene’s policies: its clinical policies for Wegovy and Zepbound, which list the health insurance marketplace as a line of business, say that use for weight management “is a benefit exclusion and will not be authorized."[1][2]
- Ambetter’s 2026 drug lists: Wegovy, Zepbound, Saxenda, and Foundayo do not appear on any of the seven state drug lists we checked: Arizona, Florida, Georgia, Illinois, North Carolina, Ohio, and Texas.[3][4][5][6][7][8][9]
- Ambetter’s own words to members: a November 21, 2025 member notice from Ambetter’s Arkansas plan said Ambetter “does not currently cover GLP-1s when prescribed solely for weight management."[10]
GLP-1 medications prescribed for type 2 diabetes are a separate category. Ozempic and Mounjaro appear on all seven drug lists we checked, with prior authorization.[3] This page is about coverage for weight management.
What Ambetter’s 2026 drug lists show
Each row comes from that state’s 2026 Ambetter formulary (drug list). All seven are marked effective January 1, 2026 and updated October 2026.
| State and plan name | Wegovy, Zepbound, Saxenda, or Foundayo listed? (as of 2026-10-16) | Diabetes GLP-1s listed | Older weight loss drugs listed |
|---|---|---|---|
| Arizona: Ambetter from Arizona Complete Health[3] | No | Ozempic, Mounjaro, Rybelsus, Trulicity, generic liraglutide | Phentermine, phendimetrazine (prior authorization) |
| Florida: Ambetter from Sunshine Health[4] | No | Same as Arizona | Same as Arizona |
| Georgia: Ambetter from Peach State Health Plan[5] | No | Same as Arizona | Same as Arizona |
| Illinois: Ambetter of Illinois[6] | No | Same as Arizona | Same as Arizona |
| North Carolina: Ambetter of North Carolina[7] | No | Same as Arizona | Same as Arizona |
| Ohio: Ambetter from Buckeye Health Plan[8] | No | Same as Arizona | Same as Arizona |
| Texas: Ambetter from Superior HealthPlan[9] | No | Same as Arizona | Same as Arizona |
On every list we checked, Ozempic, Mounjaro, Rybelsus, and Trulicity are on tier 2 with prior authorization and quantity limits. Generic liraglutide is listed with the diabetes medicines; Saxenda, the liraglutide brand approved for weight management, is not listed.
The plan documents line up with the drug lists. The 2026 Evidence of Coverage for an Ambetter Health of Texas plan excludes “weight loss prescription drugs unless otherwise listed on the formulary."[11] Because none of the GLP-1 weight loss products are on the drug lists we checked, that exclusion applies to them.
A few cautions about that table. Ambetter sells plans in other states we did not check, and their drug lists may differ. Drug lists change during the year and between plan years. A drug that is not on the list can sometimes be covered through a formulary exception, which is covered below.
Other approved uses for Wegovy and Zepbound
Centene’s clinical policies set prior authorization criteria for uses other than weight management:[1][2]
| Drug and use | What Centene’s policy requires (as of 2026-10-16, summarized) |
|---|---|
| Wegovy, lowering cardiovascular risk | Adults 18 or older with established cardiovascular disease (a prior heart attack, a prior stroke, or symptomatic peripheral artery disease), a BMI of 27 or higher, and current standard cardiovascular care. Members who also have type 2 diabetes must first have tried three of Ozempic or Rybelsus, Trulicity, liraglutide, and Mounjaro for at least 3 months (Centene says this step does not apply to Illinois marketplace requests as of January 1, 2026). |
| Wegovy injection, MASH | A diagnosis of MASH with stage F2 or F3 liver fibrosis, confirmed by biopsy or by blood and imaging tests, prescribed by or with a liver or digestive disease specialist, age 18 or older. |
| Zepbound, obstructive sleep apnea | Moderate to severe sleep apnea confirmed by a sleep test in the past 12 months, a BMI of 30 or higher, age 18 or older, at least 6 months in a weight loss program, and either continued symptoms despite regular use of a positive airway pressure (PAP) machine or not being a candidate for PAP therapy. |
| Wegovy or Zepbound, weight management | “A benefit exclusion and will not be authorized.” |
Both policies list a last review date of September 2026. Since Wegovy and Zepbound are not on the 2026 drug lists we checked, ask Ambetter whether a request for one of these uses would also need a formulary exception.
When marketplace plans change
Ambetter plans are sold as individual and family plans, so the main time to change plans is Open Enrollment. HealthCare.gov says Open Enrollment for 2027 coverage starts November 1. December 15 is the last day to pick or change plans for coverage that starts January 1, and Open Enrollment ends January 15. Outside that window, you can pick or change plans only if you qualify for a Special Enrollment Period.[12] Some states run their own marketplaces, so check your state’s dates.
Check the drug list before you pick a plan. HealthCare.gov says you can view a list of covered drugs for each plan and search for your prescription drugs when you compare plans.[13] Open the plan’s details, find the drug list, and search for the specific medication you want. A plan’s drug list for the coming year can differ from this year’s.
How to check your own Ambetter plan
Read your plan’s drug list. Find your state’s Ambetter formulary or log in to your member account. Search for semaglutide, tirzepatide, and liraglutide, and read the tier and requirement notes. A diabetes listing does not mean weight management is covered.
Call member services. Use the number on your Ambetter card and ask three questions. Does my plan cover any GLP-1 medications for weight management? If a GLP-1 is on my drug list, is it covered for weight loss or only for type 2 diabetes? Is there a formulary exception process for a drug that is not on the list? Write down the date and the name of the person you spoke with.
Read your Evidence of Coverage. Search the prescription drug section for “weight loss” to see the exclusion language for your plan.
Ask about other uses. If you have type 2 diabetes, heart disease, sleep apnea, or MASH, ask your prescriber whether a GLP-1 for that use is appropriate for you. Our guide to GLP-1 prior authorization walks through the documentation these requests usually need.
If Ambetter says no
What you do next depends on why the answer was no.
The denial was about criteria or documentation. If you were denied a medication for a covered use, such as type 2 diabetes, that is often fixable. HealthCare.gov says you must file an internal appeal within 180 days of receiving a denial notice, and if that appeal is denied, you can in many cases ask for an independent external review.[14][15] Start with our guide on what to do when insurance denies your GLP-1.
The medication you want is not on your drug list. Ask Ambetter how to request a formulary exception. Your prescriber’s documentation of why the listed alternatives are not right for you is what carries the request. For individual and small-group plans that must cover essential health benefits, federal rules require an exception process, with a decision due within 72 hours on a standard request and within 24 hours on an expedited request.[16] Your plan documents state the exact limits that apply to you.
Your plan excludes weight loss medications. An appeal generally cannot override a plan exclusion. You can compare drug lists at the next Open Enrollment and ask your prescriber whether any covered use applies to you. Beyond that, the options are outside insurance:
- Manufacturer savings and self-pay options. Novo Nordisk and Eli Lilly each publish savings and self-pay terms, and the terms change. Our page on GLP-1 savings programs compares them.
- Cash-pay telehealth programs. Some prescribe brand-name medications and some prescribe compounded medications. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name products.[17] Our page on compounded GLP-1 without insurance explains how that route works.
Prices vary by program, medication, and dose. Compare the total cost: medication, dose increases, visits, labs, shipping, membership fees, and cancellation terms. At most telehealth programs, a licensed provider reviews your health history and decides whether a prescription is appropriate. Our page on what insurance covers for weight loss and the full insurance coverage overview can help you weigh the options.
Transformation Health does not accept payment from providers. How we make money.
We're relaunching soon
We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.
Get StartedCitations
[1] Centene Corporation. “Clinical Policy: Semaglutide (Wegovy),” CP.PMN.295. Effective June 1, 2024; last review September 2026; line of business HIM/ICHRA (health insurance marketplace) and Medicaid. Accessed 2026-10-16. https://www.ambetterhealth.com/content/dam/centene/policies/pharmacy-policies/pmn/CP.PMN.295.pdf
[2] Centene Corporation. “Clinical Policy: Tirzepatide (Zepbound),” CP.PMN.298. Effective December 20, 2024; last review September 2026; line of business HIM/ICHRA (health insurance marketplace) and Medicaid. Accessed 2026-10-16. https://www.ambetterhealth.com/content/dam/centene/policies/pharmacy-policies/pmn/CP.PMN.298.pdf
[3] Ambetter from Arizona Complete Health. “2026 Formulary.” Effective January 1, 2026; updated October 2026. Accessed 2026-10-16. https://www.ambetterhealth.com/content/dam/centene/ambetteraz/pdfs/2026-az-formulary.pdf
[4] Ambetter from Sunshine Health (Florida). “2026 Formulary.” Effective January 1, 2026; updated October 2026. Accessed 2026-10-16. https://www.ambetterhealth.com/content/dam/centene/Sunshine/Ambetter/PDFs/2026-fl-formulary.pdf
[5] Ambetter from Peach State Health Plan (Georgia). “2026 Formulary.” Effective January 1, 2026; updated October 2026. Accessed 2026-10-16. https://www.ambetterhealth.com/content/dam/centene/peachstate/ambetter/PDFs/2026-ga-formulary.pdf
[6] Ambetter of Illinois. “2026 Formulary.” Effective January 1, 2026; updated October 2026. Accessed 2026-10-16. https://www.ambetterhealth.com/content/dam/centene/ambetteril/pdfs/2026-il-formulary.pdf
[7] Ambetter of North Carolina. “2026 Formulary.” Effective January 1, 2026; updated October 2026. Accessed 2026-10-16. https://www.ambetterhealth.com/content/dam/centene/ambetternc/pdfs/2026-nc-formulary.pdf
[8] Ambetter from Buckeye Health Plan (Ohio). “2026 Formulary.” Effective January 1, 2026; updated October 2026. Accessed 2026-10-16. https://www.ambetterhealth.com/content/dam/centene/Buckeye/Ambetter/PDFs/2026-oh-formulary.pdf
[9] Ambetter from Superior HealthPlan (Texas). “2026 Formulary.” Effective January 1, 2026; updated October 2026. Accessed 2026-10-16. https://www.ambetterhealth.com/content/dam/centene/Superior/Ambetter/PDFs/2026-tx-formulary.pdf
[10] Ambetter from Arkansas Health and Wellness. “GLP-1 Medications: Coverage Exclusions for Weight Loss Treatment” (member news), November 21, 2025. Accessed 2026-10-16. https://www.ambetterhealth.com/en/ar/resources/member-news/glp-1-medications-coverage-exclusions-for-weight-loss-treatment
[11] Ambetter Health of Texas, Inc. “2026 Evidence of Coverage,” plan 43480TX001-2026 (Prescription drug benefits: non-covered services and exclusions). Accessed 2026-10-16. https://api.centene.com/EOC/2026/43480TX001.pdf
[12] HealthCare.gov (Centers for Medicare and Medicaid Services). “Dates and deadlines for 2027 health insurance.” Accessed 2026-10-16. https://www.healthcare.gov/quick-guide/dates-and-deadlines/
[13] HealthCare.gov (Centers for Medicare and Medicaid Services). “Comparing plans.” Accessed 2026-10-16. https://www.healthcare.gov/choose-a-plan/comparing-plans/
[14] HealthCare.gov (Centers for Medicare and Medicaid Services). “Internal appeals.” Accessed 2026-10-16. https://www.healthcare.gov/appeal-insurance-company-decision/internal-appeals/
[15] HealthCare.gov (Centers for Medicare and Medicaid Services). “External review.” Accessed 2026-10-16. https://www.healthcare.gov/appeal-insurance-company-decision/external-review/
[16] 45 CFR 156.122(c) (prescription drug benefits: standard and expedited exception requests). Accessed 2026-10-16. https://www.law.cornell.edu/cfr/text/45/156.122
[17] U.S. Food and Drug Administration. “Compounding and the FDA: Questions and Answers.” Accessed 2026-10-16. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
Important disclosures
Coverage information on this page is current as of 2026-10-16, is general and educational, and changes frequently. It does not represent the terms of your specific plan and is not legal advice. Ambetter plans and drug lists differ by state and plan year. Confirm current benefits, drug list status, and prior authorization requirements directly with Ambetter: call the member services number on your card or read your plan documents. If you are shopping for a plan, check each plan’s list of covered drugs before you choose one.
Important: This content is for general education and is not medical advice. Talk with a licensed provider about your situation. transformationhealth.com is a website operated by Amerigo Health LLC. Transformation Health is an independent publisher. It does not provide medical care, prescribe, or sell medication, and does not give medical advice. A licensed provider decides whether a prescription is appropriate. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name products. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy or Zepbound and may differ in formulation, purity, and potency. Wegovy, Ozempic, Rybelsus, and Saxenda are trademarks of Novo Nordisk A/S. Zepbound, Mounjaro, Trulicity, and Foundayo are trademarks of Eli Lilly and Company. Ambetter is a trademark of its owner. Other product names on this page are trademarks of their respective owners. Transformation Health is not affiliated with or endorsed by Ambetter, Centene, Novo Nordisk, or Eli Lilly. Transformation Health does not accept payment from providers. How we make money.